Battelle Continues Tradition of Participation at Annual Society of Toxicology Meeting

March 22, 2007

 

Columbus, OH--Battelle, a leader in providing toxicology services to support product development for the pharmaceutical and biotechnology industries, is participating in the Society of Toxicology's (SOT) 46th Annual Meeting and ToxExpo™ in Charlotte, NC, March 25 - 29, 2007. Attendees can access Battelle staff at the ToxExpo™ booth (#821) or in one of nearly 30 poster presentations throughout the week.

 

"We are once again pleased to be a part of the tradition of the annual Society of Toxicology meeting. For over 20 years, the SOT has provided an opportunity for Battelle and our clients to discuss current topics in drug development, chemical testing and safety evaluations," says Michael Brooker, Vice President of Business Development for the BioPharmaceutical market. "This year, our focus on personal health will highlight our capabilities in safety pharmacology, toxicology, efficacy testing, and biomarkers for personalized medicine."

 

Battelle research services for the pharmaceutical and biotechnology industries include safety pharmacology, cardiovascular and respiratory physiology, pulmonary delivery, and other non-clinical safety assessment services. Analytical chemistry services are available for pre-clinical and clinical drug development and for analyzing and interpreting PK/TK data for such purposes as chemical safety evaluations, risk assessments, and/or IND applications. Battelle provides a broad range of life sciences research and development services to government and private organizations to improve the public's health through the application of science and technology to promote wellness, prevent and treat disease, and advance homeland security.

 

Battelle is the world's largest non-profit independent research and development organization, with 20,000 employees in more than 120 locations worldwide, including five national laboratories Battelle manages or co-manages for the U.S. Department of Energy. Headquartered in Columbus, Ohio, Battelle conducts $3.8 billion in R&D annually through contract research, laboratory management, and technology commercialization. Battelle provides innovative solutions to some of the world's most important problems including global climate change, sustainable energy technologies, high performance materials, next generation healthcare diagnostics and therapeutics, and advanced security solutions for people, infrastructure, and the nation. Battelle has a long history of developing successful commercial products in collaboration with its clients, ranging from products to fight diabetes, cancer, and heart disease to the development of the office copier machine (Xerox). As a non-profit charitable trust with an eye toward the future, Battelle actively supports and promotes science and math education.

 

For more information, visit www.battelle.org or contact Michael Brooker at (614) 424-6372; e-mail: brookerm@battelle.org.